Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 222
of 12Next
1:

TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.

Howlin J, Rosenkvist J, Andersson T.

Breast Cancer Res. 2008;10(2):R36. Epub 2008 Apr 24.

PMID: 18435854 [PubMed - indexed for MEDLINE]

2:

Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

Hutcheson IR, Knowlden JM, Hiscox SE, Barrow D, Gee JM, Robertson JF, Ellis IO, Nicholson RI.

Breast Cancer Res. 2007;9(4):R50.

PMID: 17686159 [PubMed - indexed for MEDLINE]

3:

Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells.

Kruger JS, Reddy KB.

Mol Cancer Res. 2003 Sep;1(11):801-9.

PMID: 14517342 [PubMed - indexed for MEDLINE]

4:

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.

Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE.

Breast Cancer Res. 2007;9(5):R63.

PMID: 17897439 [PubMed - indexed for MEDLINE]

5:

[Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells]

Kang CS, Pu PY, Wang GX, Li YH, Dong L, Wang H.

Zhonghua Yi Xue Za Zhi. 2004 Sep 17;84(18):1503-8. Chinese.

PMID: 15500708 [PubMed - indexed for MEDLINE]

6:

Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells.

Golubovskaya V, Beviglia L, Xu LH, Earp HS 3rd, Craven R, Cance W.

J Biol Chem. 2002 Oct 11;277(41):38978-87. Epub 2002 Aug 7.

PMID: 12167618 [PubMed - indexed for MEDLINE]

7:

Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.

Dorssers LC, van Agthoven T, Brinkman A, Veldscholte J, Smid M, Dechering KJ.

Breast Cancer Res. 2005;7(1):R82-92. Epub 2004 Nov 16.

PMID: 15642172 [PubMed - indexed for MEDLINE]

8:

Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.

Hirsch DS, Shen Y, Wu WJ.

Cancer Res. 2006 Apr 1;66(7):3523-30.

PMID: 16585176 [PubMed - indexed for MEDLINE]

9:

GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.

Morishige M, Hashimoto S, Ogawa E, Toda Y, Kotani H, Hirose M, Wei S, Hashimoto A, Yamada A, Yano H, Mazaki Y, Kodama H, Nio Y, Manabe T, Wada H, Kobayashi H, Sabe H.

Nat Cell Biol. 2008 Jan;10(1):85-92. Epub 2007 Dec 16.

PMID: 18084281 [PubMed - indexed for MEDLINE]

10:

Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.

Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N.

Cancer Res. 2005 Dec 1;65(23):11018-25.

PMID: 16322251 [PubMed - indexed for MEDLINE]

12:

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

PMID: 17980029 [PubMed - indexed for MEDLINE]

13:

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).

Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez JA, De Llorens R, Colomer R.

Int J Mol Med. 2007 Jul;20(1):3-10. Review.

PMID: 17549382 [PubMed - indexed for MEDLINE]

16:

Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.

Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L.

J Biol Chem. 2006 Sep 8;281(36):25903-14. Epub 2006 Jul 17.

PMID: 16847054 [PubMed - indexed for MEDLINE]

17:

An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor.

Kang CS, Pu PY, Li YH, Zhang ZY, Qiu MZ, Huang Q, Wang GX.

J Neurooncol. 2005 Sep;74(3):267-73.

PMID: 16132520 [PubMed - indexed for MEDLINE]

18:

Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.

Shida D, Fang X, Kordula T, Takabe K, Lépine S, Alvarez SE, Milstien S, Spiegel S.

Cancer Res. 2008 Aug 15;68(16):6569-77.

PMID: 18701480 [PubMed - indexed for MEDLINE]

20:

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

Hiscox S, Morgan L, Green TP, Barrow D, Gee J, Nicholson RI.

Breast Cancer Res Treat. 2006 Jun;97(3):263-74. Epub 2005 Dec 7.

PMID: 16333527 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 222
of 12Next